Put two packs of CBD seeds next to each other, one labelled 1:1 and the other 20:1, and the two look identical: same brand packaging, the same seed count, contents that nobody’s eye can tell apart. Run them side by side and they go their separate ways from the very first step and do not meet again. The reason is a single gene, and the clearest way to see what it does is to follow the two packs along each stage they go through: the cross that produced them, the seed, the seedling, the flower room, the harvest, the jar, the lab bench and the border. The ratios quoted as reference points throughout are taken from the range at https://calmcbdseeds.com, which runs 1:1, 2:1 and 20:1 and a highest line at about 30 to one; the biology holds the same whichever shop the packs came from.
Before the Seed Exists
Cannabis decides if it is going to produce THC or CBD at one position on the genome. The gene there exists in two versions: one builds the enzyme that converts the shared precursor into THCA, the other the enzyme that turns it into CBDA. Each plant carries two copies, one received from either parent, and the combination sets the chemotype. Two THC copies make a THC-dominant plant. Two CBD copies give a CBD-dominant one. One of each gives a balanced plant, since the two versions are codominant and not one of them overrides the other.
The 1:1 pack was bred by crossing two balanced plants, both holding one copy of each version. The 20:1 pack was made by pairing two plants which each carry two CBD copies and not a single THC copy between them. That one difference at the bench decides everything downstream, and it is fully inside the seed long before it is packed.
Stage Two: Inside the Seed
Cross two balanced plants and the seeds sort out by the simplest rule in genetics: a quarter get two THC copies, a quarter get two CBD copies, half inherit one of each. In a pack of 10 seeds that works out to, on average, two or three THC-dominant seeds, two or three CBD-dominant ones, and about five true balanced ones. The pack is labelled by its parents, and for half its contents the label fits; in the case of the other half it does not. Calm CBD Seeds states the expected split on every balanced line, which means the buyer knows before sowing that a share of the plants will differ from the headline ratio.
The 20:1 pack carries no such split. Every seed received a CBD copy from both parents, every plant will be CBD-dominant, and the ratio on the foil applies to every one of them, give or take the ordinary variation in the amount of much total cannabinoid an given plant builds. Breeders describe these lines “breed true” for chemotype; the term refers to exactly this lack of variation.
Weeks One to Four
At this stage the two packs appear the same again, and the resemblance lasts further than many growers expect. Chemotype shows no mark on a seedling. Leaf shape, colour, stem spacing and the speed of growth rate are controlled by different genes entirely, and the different chemotypes of plant in the 1:1 pack come up indistinguishably beside one another and from each plant in the 20:1 pack.
One real distinction at this stage comes from ancestry not chemotype. Strains with strong hemp genetics, and that includes a number of older CBD-dominant lines, tend to grow taller and fill out more sparsely. A well-worked 20:1 strain behaves like a normal indoor hybrid; a young one still shows the hemp in its shape. Neither habit says a thing about the ratio in the flower.
When the Resin Comes In
In flower the two packs start to give hints, and the majority of them point the wrong way. Trichome density is the first one a grower judges, and it was a reasonable rule: first-generation CBD-dominant lines showed visibly less frost than their THC cousins, an unwanted legacy from hemp. Modern lines have mostly erased that gap, and a less frosted plant from the 20:1 pack may still come in precisely where the foil promised. Trichome density and chemotype are inherited separately.
Smell is an even poorer guide. The terpene chemistry sits on still other genes, so the THC-dominant plant sitting in the 1:1 pack can smell indistinguishable to the balanced one next to it, and both can be identical to a plant from the 20:1 pack. Growers who try to separate a balanced pack by nose in week eight are guessing, which is no any better than leaving the plants sorting at all.
How Late Is Too Late
At this stage the two packs diverge in a way that favours the grower of the 20:1 pack and the CBD-dominant plants hidden in the 1:1 pack. CBDA breaks down more gradually than THCA, so a CBD-dominant plant left a week past its peak retains the bulk of its cannabinoid content, where a THC-dominant one under the same neglect has by then started shedding THC into CBN. The usual trichome rules nonetheless applies; it holds on account of the terpenes, which degrade on any plant whatever the chemotype, and a late, rushed CBD flower tastes of little whatever the test result is.
Stage Six: The Jar
The 20:1 pack can go into one jar. Each plant from it holds roughly the same ratio, and mixing them changes nothing anyone would measuring. The 1:1 pack cannot be treated that way. Pool its 10 plants in a single jar and the contents is a mixture that no foil ever predicted, skewed by which plants yielded biggest, and no later test can untangle the plants that went in.
The habit that prevents the grief is dull: cut the balanced pack plant by plant, cure every one apart, number them, and try each one plant at a time before the crop is combined. This is the only point in the entire grow where the three chemotypes of plant in the 1:1 pack can still be kept apart without a laboratory, and only for the reason that each is at that moment in its own bag.
Stage Seven: The Lab Report
Submit a sample from each jar to a laboratory and the two packs finally become readable. For the 20:1 pack the reports come back grouped tightly near the stated ratio, varying mainly in total cannabinoid content not in balance. For the 1:1 pack they come back in three clusters: some plants showing almost all THC, a few with nearly all CBD, and the rest somewhere around one to one. No part of this pattern is a failure; it is the bench cross expressed as numbers.
Over-the-counter test kits are sold for growers without a laboratory, and the majority of them detect whether THC is there rather than how much. That is enough to separate the THC-dominant plants out of a balanced pack and not to assign a ratio to the rest, and that matches the commonest need: finding out what of the 10 jars is going to catch out someone.
Hemp Threshold Versus Chemotype
The last stage at which the two packs diverge is in law, and it catches growers who assumed “CBD” meant “hemp”. Most countries classify hemp by a THC limit, a small fraction of a percent of dry weight, and the exact number varying from country and over time. A plant from the 20:1 pack producing twenty percent CBD at twenty to one at the same time makes around one percent THC, and that is many times above the majority of thresholds. Compliant cultivars are selected to hold total cannabinoid content low so the THC share remains below the line at maturity; CBD flower lines are selected for high content and allow the THC scale with it. A seller that gives only a ratio is selling a flower line; anyone who needs a compliant crop should ask for a tested THC figure at maturity and buy no line that cannot show one.
Beyond the threshold issue, the word on the foil alters nothing about the law on the seed itself. Where owning cannabis seeds is lawful and germinating them is not, the 1:1 pack and the 20:1 pack fall in the same rule as any other pack. Where the plant is legal outright, the choice between them is the grower’s and nothing else’s. No part of this page is legal advice, and the rule which counts is the one in the place the seed is going to be grown, not the one where it was bought.
